Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1988 1
1990 1
1991 4
1992 6
1993 6
1994 8
1995 6
1996 8
1997 1
1998 5
1999 7
2000 6
2001 6
2002 4
2003 5
2004 7
2005 19
2006 14
2007 18
2008 11
2009 10
2010 15
2011 14
2012 13
2013 9
2014 10
2015 7
2016 8
2017 7
2018 4
2019 9
2020 20
2021 10
2022 9
2023 7
2024 10

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

274 results

Results by year

Filters applied: . Clear all
Page 1
Biologics and airway remodeling in severe asthma.
Varricchi G, Ferri S, Pepys J, Poto R, Spadaro G, Nappi E, Paoletti G, Virchow JC, Heffler E, Canonica WG. Varricchi G, et al. Among authors: virchow jc. Allergy. 2022 Dec;77(12):3538-3552. doi: 10.1111/all.15473. Epub 2022 Aug 23. Allergy. 2022. PMID: 35950646 Free PMC article. Review.
A2BCD: a concise guide for asthma management.
Lommatzsch M, Brusselle GG, Levy ML, Canonica GW, Pavord ID, Schatz M, Virchow JC. Lommatzsch M, et al. Among authors: virchow jc. Lancet Respir Med. 2023 Jun;11(6):573-576. doi: 10.1016/S2213-2600(22)00490-8. Epub 2023 Jan 27. Lancet Respir Med. 2023. PMID: 36716752 Review.
Disease-modifying anti-asthmatic drugs.
Lommatzsch M, Brusselle GG, Canonica GW, Jackson DJ, Nair P, Buhl R, Virchow JC. Lommatzsch M, et al. Among authors: virchow jc. Lancet. 2022 Apr 23;399(10335):1664-1668. doi: 10.1016/S0140-6736(22)00331-2. Lancet. 2022. PMID: 35461560 Review. No abstract available.
Allergen immunotherapy for allergic asthma.
Virchow JC, Pfaar O, Lommatzsch M. Virchow JC, et al. Allergol Select. 2024 Jan 12;8:6-11. doi: 10.5414/ALX02451E. eCollection 2024. Allergol Select. 2024. PMID: 38249819 Free PMC article. Review.
Severe asthma: definition, diagnosis and treatment.
Lommatzsch M, Virchow JC. Lommatzsch M, et al. Among authors: virchow jc. Dtsch Arztebl Int. 2014 Dec 12;111(50):847-55. doi: 10.3238/arztebl.2014.0847. Dtsch Arztebl Int. 2014. PMID: 25585581 Free PMC article. Review.
Pioneering a paradigm shift in asthma management: remission as a treatment goal.
Lommatzsch M, Buhl R, Canonica GW, Ribas CD, Nagase H, Brusselle GG, Jackson DJ, Pavord ID, Korn S, Milger K, Taube C, Virchow JC. Lommatzsch M, et al. Among authors: virchow jc. Lancet Respir Med. 2024 Feb;12(2):96-99. doi: 10.1016/S2213-2600(23)00415-0. Epub 2023 Dec 7. Lancet Respir Med. 2024. PMID: 38071999 No abstract available.
Allergisches Asthma – Behandlungsoptionen.
Virchow JC. Virchow JC. Drug Res (Stuttg). 2020 Nov;70(S 01):S6. doi: 10.1055/a-1119-2654. Epub 2020 Nov 17. Drug Res (Stuttg). 2020. PMID: 33202465 German. No abstract available.
Severe eosinophilic asthma: a roadmap to consensus.
Buhl R, Humbert M, Bjermer L, Chanez P, Heaney LG, Pavord I, Quirce S, Virchow JC, Holgate S; expert group of the European Consensus Meeting for Severe Eosinophilic Asthma. Buhl R, et al. Among authors: virchow jc. Eur Respir J. 2017 May 1;49(5):1700634. doi: 10.1183/13993003.00634-2017. Print 2017 May. Eur Respir J. 2017. PMID: 28461308 Free article. No abstract available.
274 results